Drexel University College of Medicine Sep 2013 - Nov 2017
Adjunct Professor
Drexel University Aug 1, 2011 - Sep 2014
Assistant Teaching Professor
Doretta Discovery Services Aug 1, 2011 - Sep 2014
Owner and Cadd Specialist
The College of New Jersey Aug 1, 2011 - Sep 2014
Adjunct Faculty
Monmouth University Aug 2011 - Jan 2012
Adjunct Faculty
Education:
Temple University 1983 - 1988
Doctorates, Doctor of Philosophy, Organic Chemistry
University of Virginia 1977 - 1980
Bucknell University 1973 - 1977
Bachelors, Bachelor of Science, Chemistry
Jackson Memorial Hign School 1969 - 1973
High School
Skills:
Drug Design Organic Chemistry Qsar Virtual Screening Computational Chemistry Biotechnology Drug Discovery Chemistry Cheminformatics Biomarker Discovery Homology Modeling Research Gpcrs Modeling Medicinal Chemistry Life Sciences Molecular Modeling Biochemistry Data Mining Bioinformatics Science Molecular Dynamics Schrodinger Library Computational Biology High Throughput Screening Lifesciences Organic Synthesis Drug Development Pharmacology Informatics Biophysics Physical Chemistry Protein Protein Interactions Synthetic Organic Chemistry Library Design
Languages:
English French Italian German
Us Patents
Urea Antagonists Of P2Yreceptor Useful In The Treatment Of Thrombotic Conditions
Hannguang J. Chao - Lawrenceville NJ, US Huji Tuerdi - Yardley PA, US Timothy F. Herpin - Princeton NJ, US Jacques Yves Roberge - Princeton NJ, US Yalei Liu - Hilsborough NJ, US R. Michael Lawrence - Yardley PA, US Robert P. Rehfuss - North Wales PA, US Charles G. Clark - Cherry Hill NJ, US Jennifer X. Qiao - Princeton NJ, US Timur Gungor - Pennington NJ, US Patrick Y. S. Lam - Chadds Ford PA, US Tammy Wang - Lawrenceville NJ, US Rejean Ruel - Saint Lambert, CA Alexandre L'Heureux - Ste-Julie, CA Carl Thibeault - Mascouche, CA Gilles Bouthillier - Mercier, CA Dora M. Schnur - Hamilton NJ, US
Assignee:
Bristol Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4412 A61K 31/444 C07D 213/60 C07D 213/72
US Classification:
514332, 546255, 546304, 514352
Abstract:
The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Yreceptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Yreceptor activity.
Trisubstituted Heteroaromatic Compounds As Calcium Sensing Receptor Modulators
Wu Yang - Princeton Junction NJ, US John K. Dickson - Apex NC, US Christopher B. Cooper - Lawrenceville NJ, US Dharmpal S. Dodd - Princeton NJ, US Zheming Ruan - Dayton NJ, US Dora M. Schnur - Hamilton NJ, US
Hannguang J. Chao - Lawrenceville NJ, US Huji Tuerdi - Yardley PA, US Timothy F. Herpin - Princeton NJ, US Jacques Y. Roberge - Princeton NJ, US Yalei Liu - Hillsborough NJ, US Michael R. Lawrence - Yardley PA, US Robert P. Rehfuss - North Wales PA, US Charles G. Clark - Cherry Hill NJ, US Jennifer X. Qiao - Princeton NJ, US Timur Gungor - Pennington NJ, US Patrick Y. S. Lam - Chadds Ford PA, US Tammy C. Wang - Lawrenceville NJ, US Rejean Ruel - Saint-Lambert, CA Alexandre L'Heureux - Ste Julie, CA Carl Thibeault - Mascouche, CA Gilles Bouthillier - Mercier, CA Dora M. Schnur - Hamilton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/155 C07C 275/28
US Classification:
514596, 564 48
Abstract:
The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Yreceptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Yreceptor activity.